Analysis of Blood Culture and antibacterial Drugs in Classical empiric therapy vs. D-index-guided early therapy using micafungin for persistent febrile neutropenia.(ABCD-CEDMIC trial)
Not Applicable
- Conditions
- Hematological malignancies(acute leukemia, myelodysplastic syndrome, lymphoma, myeloma, and so on)
- Registration Number
- JPRN-UMIN000040390
- Lead Sponsor
- Japan Febrile Neutropenia Study Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 423
Inclusion Criteria
Not provided
Exclusion Criteria
1)Previous history of invasive fungal infection 2)Receiving antifungal agents other than prophylactic administration 3)Suspected active infection 4)Planned to receive antifungal prophylaxis with polyenes or candins 5)Allergic reaction to candins 6)Pregnant or possibly pregnant 7)HIV positive 8)Not suitable for thie trial judged by attending physicians
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To detect the pathogens and confirm the risk factor
- Secondary Outcome Measures
Name Time Method